NicholasEJohnsonMD

PubMed

• 12 citations
  Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial.
  Charles A Thornton, Richard Thomas Moxley 3rd, Katy Eichinger, Chad Heatwole, Laurence Mignon
  The Lancet. Neurology. 2023-03-01
• 72 citations
  Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening Program.
  Nicholas E. Johnson, Russell J Butterfield, Katie Mayne, Tara M. Newcomb, Carina Imburgia
  Neurology. 2021-01-20
• 25 citations
  Repeat-associated RNA structure and aberrant splicing.
  Melissa Hale, Nicholas E. Johnson, J. Andrew Berglund
  Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms. 2019-11-01

Journal Articles

• The Impact of Congenital and Childhood Myotonic Dystrophy on Quality of Life: A Qualitative Study of Associated Symptoms  
  Johnson NE, Luebbe E, Eastwood E, Chin N, Moxley RT 3rd, Heatwole CR, J Child Neurol, 1/1/2013
• New insights about the incidence, multisystem manifestations, and care of patients with congenital myotonic dystrophy  
  Hilbert JE, Johnson NE, Moxley RT 3rd, J Pediatr, 1/1/2013
• Myotonia congenita in a patient who presented with diplopia and ptosis [Letter to the editor]  
  Odrzywolski K, Johnson NE, Twydell PT, Muscle Nerve, 1/1/2013
• Patient Reported Impact of Symptoms in Myotonic Dystrophy Type-1: (PRISM-1)  
  Heatwole CR, Bode R, Johnson NE, Quinn C, Martens WB, McDermott MP, et al, Neurology, 1/1/2012
• Noninvasive microscopic imaging of sensory receptors in neuropathy  
  Johnson NE, Herrmann DN, Neurology, 1/1/2012
• Education research: neurology training reassessed The 2011 American Academy of Neurology Resident Survey results  
  Johnson NE, Maas MB, Coleman M, Jozefowicz R, Engstrom J, Neurology, 1/1/2012
• Plasma Exchange vs Intravenous Immunoglobulin for Myasthenia Gravis Crisis: An acute hospital cost comparison study  
  Heatwole CR, Johnson NE, Holloway R, Noyes K, J Clin Neuromuscular Dis, 1/1/2011
• Plasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: an acute hospital cost comparison study  
  Heatwole C, Johnson N, Holloway R, Noyes K, Neuromuscular Dis, 1/1/2011
• Rapid resolution of severe neuralgic amyotrophy after treatment with corticosteroids and intravenous immunoglobulin [Letter to the editor]  
  Johnson NE, Petraglia AL, Huang JH, Logigian EL, Muscle Nerve, 1/1/2011
• Why Neurology Residents Need to Get Involved in Health System Reform  
  Johnson N, Neurology Today, 1/1/2010
• Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus  
  Johnson N, Henry C, Fessler AJ, Dalmau J, Neurology, 1/1/2010
• Laboratory abnormalities in ambulatory patients with myotonic dystrophy type 1  
  Heatwole CR, Miller J, Martens B, Moxley RT 3rd, Arch Neurol, 1/1/2006
• Staufen- and FMRP-containing neuronal RNPs are structurally and functionally related to somatic P bodies  
  Barbee SA, Estes PS, Cziko AM, Hillebrand J, Luedeman RA, Coller JM, Johnson N, Howlett IC, Geng C, Ueda R, Brand AH, Newbury SF, Wilhelm JE, Levine RB, Nakamura A, Pa..., Neuron, 1/1/2006
• Join now to see all